REG - Spire Healthcare Grp - Capital Markets Event

Spire HealthcareAnnouncement

17/04/2024 07:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240417:nRSQ8687Ka&default-theme=true

RNS Number : 8687K  Spire Healthcare Group PLC  17 April 2024

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Capital Markets Event

 

17 April 2024

 

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group
in the UK, will today host a Capital Markets Event at the offices of
Instinctif Partners, London, starting at 10.00am.

 

The event will be led by CEO Justin Ash and involve presentations by senior
executives covering the following topics:

 

·      Hospitals Business deep dive - with a focus on the savings
programme announced at the Group's FY23 results and activities to further
enhance hospital margins

·      Overview of Spire Occupational Health

·      Introduction to Vita Health Group

 

The event is open to institutional investors, sell-side analysts and lending
banks only. To request a place at the event, please contact Instinctif
Partners at Spire@Instinctif.com (mailto:Spire@Instinctif.com) .

 

For those who cannot attend in person, the presentation will also be
accessible via live Zoom webcast. Click the following link to register in
advance for the live Zoom webcast and to receive access details:
https://spirehealthcare.zoom.us/webinar/register/WN_oWnMSbVmQGisjIaTqS5MSg
(https://spirehealthcare.zoom.us/webinar/register/WN_oWnMSbVmQGisjIaTqS5MSg)

 

A recording of the webcast will be made available following the event on the
Spire Healthcare website, https://www.investors.spirehealthcare.com
(https://www.investors.spirehealthcare.com)

 

No new material information will be disclosed during the event.

 

The next trading update will be announced in three weeks' time at 7.00am on 9
May 2024, ahead of the Company's AGM, in line with usual practice.

 

- Ends -

 

For further information please contact:

 

 Spire Healthcare                                  +44 (0)7974 982 512

 Angus Prentice - Director of Investor Relations

 Instinctif Partners

 Damian Reece                                      +44 (0)7931 598 593

 Guy Scarborough                                   +44 (0)7917 178 920

 Jeremy Durrant                                    +44 (0)7792 918 648

 

 

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

 

About Spire Healthcare

Spire Healthcare (https://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 39 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.

 

Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.

 

Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good,'
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUNVNRSRUSAAR